Norwegian Spontaneous Coronary Artery Dissection Study

Recruiting now

Conditions studied: SCAD, Myocardial Infarction (MI), Women

In brief

The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).

Key facts

Study ID

NCT07317323

Run by

Oslo University Hospital

People needed

300

Starts

2025-04-01

Expected to finish

2035-12-31

Last updated by the study team

2026-01-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Spontaneous coronary artery dissection

You may not qualify if…

• Severe kidney failure
• Severe allergic reaction to contrast

Where it is running

• Haukeland University Hospital — Bergen, Norway (enrolling)
• Akershus University Hospital — Oslo, Norway (enrolling)
• Rikshospitalet, Oslo University Hospital — Oslo, Norway (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.